Clinical Trial Update: Low Dose Naltrexone-buprenorphine Transfer to Vivitrol Injection in Opioid Dependence [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated transitioning opioid-dependent patients from low-dose naltrexone-buprenorphine to extended-release naltrexone (Vivitrol); results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Low-dose naltrexone-buprenorphine (Naltrexone-buprenorphine)
• Naltrexone (Naltrexone)
• Vivitrol (naltrexone extended-release injectable)
• buprenorphine (buprenorphine)

Snippet

Sponsor: Paolo Mannelli | Conditions: Opiate Dependence | Phase 2 | Status: COMPLETED | Results posted: 2016-06-01